The Design and Initial Survival Analysis Outcomes from the STAMPEDE Trial - an eSeries supported by SIU’s corporate sponsor, Sanofi Oncology
SIU Academy®. James N. 12/15/15; 108697
Topic: Research
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
After viewing this presentation the participant will be able to:
- Explain the changing prognosis of men starting long-term ADT
- Define the role of radiotherapy in M0 disease
- Discuss the role of chemotherapy in hormone-naïve prostate cancer
- Understand the evolving data on use of zoledronic acid in prostate cancer
- Explain the changing prognosis of men starting long-term ADT
- Define the role of radiotherapy in M0 disease
- Discuss the role of chemotherapy in hormone-naïve prostate cancer
- Understand the evolving data on use of zoledronic acid in prostate cancer
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}